🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size
60 Servings
Non-Nutrient/Non-Botanical Product Type
60% Evidence Coverage

Supplement Facts — Evidence Check

30 mg (150% DV)
✅ 2.1× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 30mg UL 35mg
Brown Seaweed Blend
250 mg
250 mg
📊 Market median: 500.0mg (861 products) 📚 60 studies (Tier A: 4, B: 13)
This product: 250mg
📊 Market median: 180.0mg (239 products) 📚 43 studies (Tier A: 1, B: 19)
This product: 200mg UL 400mg
📊 Market median: 300.0mg (68 products)
Median 300.0mg This product: 135mg

Other Ingredients

Microcrystalline Cellulose Magnesium Stearate Silica Vegetarian Cellulose

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested use: For best results, take 30 minutes prior to a meal.

⚠️ Warnings & Precautions

Tamper evident - Do not use if inner seal is broken or missing.

Consult your healthcare professional prior to use if you are pregnant, nursing, taking any medication or have any medical condition.

🧪 Formulation Notes

Free of: yeast, corn, wheat, sugar, soy, dairy, citrus, preservatives, artificial colors or flavors added. GLUTEN FREE

- VEGETARIAN FORMULATION

Additional Information

MADE IN THE USA

svetol(R)

B E

BRICKERLABS(r) science that makes sense

Carnipure(TM)

Supports Fat Metabolism and An Essential Ally Against Hidden Sugars

InSea2(R)

- NON GMO

Product Details

UPC / SKU 0 42239 36120 0
DSLD Entry Date 2014-10-27
Product Type Non-Nutrient/Non-Botanical
Form Capsule
Brand Bricker Labs
DSLD ID 38612
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →